Efficacy and safety of anlotinib plus penpulimab as second-line treatment for small cell lung cancer: A multicenter, open-label, single-arm phase II trial
Titel:
Efficacy and safety of anlotinib plus penpulimab as second-line treatment for small cell lung cancer: A multicenter, open-label, single-arm phase II trial
Auteur:
Zhang, Changgong Chen, Jianhua Wu, Huijuan Wang, Jun Gao, Liying Zhao, Jun Sun, Yan Jia, Zhongyao Mu, Xinlin Bai, Chunmei Wang, Rui Wu, Kailiang Liu, Qiang Shi, Yuankai